|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.86/--
|
企業價值
135.76M
|
資產負債 |
每股賬面淨值
2.22
|
現金流量 |
現金流量率
--
|
損益表 |
收益
6.00M
|
每股收益
--
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/16 23:44 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. |